Analysis of GCase activity in the blood of PD patients has demonstrated that patients with severe GBA1 mutations exhibit a greater reduction in GCase activity when compared to those with mild GBA1 mutations and risk variants (56). The gene discussed is GBA1; the disease is Parkinson disease.